Neurocognitive effects of cannabis: Lessons learned from human experimental studies

被引:17
作者
Colizzi, Marco [1 ]
Bhattacharyya, Sagnik [1 ]
机构
[1] Kings Coll London, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England
来源
PSYCHEDELIC NEUROSCIENCE | 2018年 / 242卷
基金
英国医学研究理事会;
关键词
Cannabis; Delta-9-tetrahydrocannabinol; Cannabidiol; Tolerance; Cognition; fMRI; Dopamine; Glutamate; Neurophysiology; Neurochemistry; ACUTE ORAL DELTA(9)-TETRAHYDROCANNABINOL; FUNCTIONAL GENETIC-VARIATION; G-PROTEIN ACTIVATION; WORKING-MEMORY; PREFRONTAL CORTEX; SMOKED MARIJUANA; DOUBLE-BLIND; INTRAVENOUS DELTA-9-TETRAHYDROCANNABINOL; PHARMACOKINETIC PROPERTIES; HIPPOCAMPAL-NEURONS;
D O I
10.1016/bs.pbr.2018.08.010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The following chapter offers an overview of results of experimental studies conducted among healthy individuals examining the effects of acute administration of Delta 9-THC and other cannabinoids, alone or in combination, on brain function and behavior, also as a function of previous cannabis exposure. In light of their methodological design, these studies have advanced the understanding of the neurobiological mechanisms increasing the risk of long-lasting cognitive dysfunction as well as psychosis in regular cannabis users. Also, direct and indirect evidence supports an alteration of different neurotransmitters, such as dopamine, glutamate, and gamma-aminobutyric acid, in modulating the manifestation of neurocognitive dysfunction and psychosis in the context of both acute and chronic cannabis exposure. Future multimodal neuroimaging studies will integrate the longitudinal information to track the long-term changes in brain neurochemistry and neurophysiology as well as other potential biomarkers induced by sustained cannabis use.
引用
收藏
页码:179 / 216
页数:38
相关论文
共 187 条
[1]   The effects of cannabinoids on the brain [J].
Ameri, A .
PROGRESS IN NEUROBIOLOGY, 1999, 58 (04) :315-348
[2]   Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers [J].
Anizan, Sebastien ;
Milman, Garry ;
Desrosiers, Nathalie ;
Barnes, Allan J. ;
Gorelick, David A. ;
Huestis, Marilyn A. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (26) :8451-8461
[3]  
[Anonymous], LANCET
[4]  
[Anonymous], EXP CLIN PSYCHOPHARM
[5]  
[Anonymous], 2017, HLTH EFF CANN CANN C
[6]   Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids [J].
Appiah-Kusi, E. ;
Leyden, E. ;
Parmar, S. ;
Mondelli, V. ;
McGuire, P. ;
Bhattacharyya, S. .
PSYCHOLOGICAL MEDICINE, 2016, 46 (01) :27-45
[7]   Effects of cannabidiol treatment on cortisol response to social stress in subjects at high risk of developing psychosis [J].
Appiah-Kusi, Elizabeth ;
Mondelli, Valeria ;
McGuire, Philip ;
Bhattacharyya, Sagnik .
PSYCHONEUROENDOCRINOLOGY, 2016, 71 :23-24
[8]   Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers [J].
Atakan, Z. ;
Bhattacharyya, S. ;
Allen, P. ;
Martin-Santos, R. ;
Crippa, J. A. ;
Borgwardt, S. J. ;
Fusar-Poli, P. ;
Seal, M. ;
Sallis, H. ;
Stahl, D. ;
Zuardi, A. W. ;
Rubia, K. ;
McGuire, P. .
PSYCHOLOGICAL MEDICINE, 2013, 43 (06) :1255-1267
[9]  
BABOR TF, 1975, ARCH GEN PSYCHIAT, V32, P1548
[10]   Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study [J].
Barkus, Emma ;
Morrison, Paul D. ;
Vuletic, D. ;
Dickson, John C. ;
Ell, Peter J. ;
Pilowsky, Lyn S. ;
Brenneisen, Rudolf ;
Holt, David W. ;
Powell, John ;
Kapur, Shitij ;
Murray, Robin M. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (11) :1462-1468